Stuart A. Arbuckle, EVP, COO at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 11,767 shares at $420.24 ($5.0M) on 2024-02-12, disclosed to the SEC on 2024-02-13.
Scheduled sale ($5.0M) by EVP, COO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $422.74 | 3,177 | $1.3M | 27.1% |
| 2 | $420.24 | 4,295 | $1.8M | 36.4% |
| 3 | $420.24 | 4,295 | $1.8M | 36.4% |
| Total | $420.91 avg | 11,767 | $5.0M | 100% |
| Filing → |
| VRTX | SELL | 2024-02-23 | $3.0M | — | Filing → |
| VRTX | SELL | 2024-02-21 | $4.0M | — | Filing → |
| VRTX | SELL | 2023-12-15 | $3.4M | — | Filing → |